Expression of IGFBP2 in gastric carcinoma and relationship with clinicopathologic parameters and cell proliferation

Digestive Diseases and Sciences

Volumn 52, Issue 1, 2007, Pages 248-253

  Zhang, Lihua ^a   Huang, Wenbin ^a   Chen, Jieyu ^a   Zhou, Xiaojun ^a   Lu, Zhenfeng ^a   Zhou, Hangbo ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Cell proliferation; Gastric carcinoma; Insulin like growth factor binding protein; Ki 67

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; MONOCLONAL ANTIBODY KI 67;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CARCINOMA;

ADULT; AGED; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; GASTRIC MUCOSA; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; STOMACH NEOPLASMS;

EID: 33846294444     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9358-z     Document Type: Article

References (29)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2000) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94:153-156
2. Konturek PC, Konturek SJ, Sulekova Z, Meixner H, Bielanski W, Starzynska T, Karczewska E, Marlicz K, Stachura J, Hahn EG (2001) Expression of hepatocyte growth factor, transforming growth factor alpha, apoptosis related proteins Bax and Bcl-2, and gastrin in human gastric cancer. Aliment Pharmacol Ther 15:989-999
3. Han SU, Lee JH, Kim WH, Cho YK, Kim MW (1999) Significant correlation between serum level of hepatocyte growth factor and progression of gastric carcinoma. World J Surg 23:1176-1180
4. Rosenfeld RG, Roberts CT (eds) (1999) The IGF System. Totowa, NJ: Humana Press Inc.
5. LeRoith D (1996) Insulin-like growth factor receptors and binding proteins. Baillieres Clin Endocrinol Metab 10:49-73
6. Rajaram S, Baylink DJ, Mohan S (1997) Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev 18:801-831
7. Wetterau LA, Moore MG, Lee KW, Shim ML, Cohen P (1999) Novel aspects of the insulin-like growth factor binding proteins. Molecular Genetics Metab 68:161-181
8. Hoeflich A, Lahm H, Blum W, Kolb H, Wolf E (1998) Insulin-like growth factor-binding protein-2 inhibits proliferation of human embryonic kidney fibroblasts and of IGF-responsive colon carcinoma cell lines. FEBS Lett 434:329-334
9. Hoeflich A, Nedbal S, Blum WF, Erhard M, Lahm H, Brem G, Kolb HJ, Wanke R, Wolf E (2001) Growth inhibition in giant growth hormone transgenic mice by overexpression of insulin-like growth factor-binding protein-2. Endocrinology 142:1889-1898
10. Flyvbjerg A, Mogensen O, Mogensen B, Nielsen OS (1997) Elevated serum insulin-like growth factor-binding protein 2 (IGFBP-2) and decreased IGFBP-3 in epithelial ovarian cancer: correlation with cancer antigen 125 and tumor-associated trypsin inhibitor. J Clin Endocrinol Metab 82:2308-2313
11. El Atiq F, Garrouste F, Remacle-Bonnet M, Sastre B, Pommier G (1994) Alterations in serum levels of insulin-like growth factors and insulin-like growth-factor binding proteins in patients with colorectal cancer. Int J Cancer 57:491-497
12. Ho PJ, Baxter RC (1997) Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia. Clin Endocrinol 46:333-342
13. Muller HL, Oh Y, Lehrnbecher T, Blum WF, Rosenfeld RG (1994) Insulin-like growth factor-binding protein-2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia. J Clin Endocrinol Metab 79:428-434
14. Schutt BS, Langkamp M, Rauschnabel U, Ranke MB, Elmlinger MW (2004) Integrin-mediated action of insulin-like growth factor binding protein-2 in tumor cells. J Mol Endocrinol 32:859-868
15. Moore MG, Wetterau LA, Francis MJ, Peehl DM, Cohen P (2003) Novel stimulatory role for insulin-like growth factor binding protein-2 in prostate cancer cells. Int J Cancer 105:14-19
16. Yi HK, Hwang PH, Yang DH, Kang CW, Lee DY (2001) Expression of the insulin-like growth factors (IGFs) and the IGF-binding proteins(IGFBPs) in human gastric cancer cells. Eur J Cancer 37:2257
17. He T, Wu XT, Yang ZM, Da MX, Zhang MM, Qian K (2005) IGFBP-2 mRNA expression in gastric cancer tissues and its roles in proliferation, differentiation and peritoneal metastasis of gastric cancer. SiChuan Da Xue Xue Bao Yi Xue Ban 36:187-189
18. Pinto-de-Sousa J, David L, Seixas M, Pimenta A (2001) Clinicopathologic profiles and prognosis of gastric carcinomas from the cardia, fundus/body and antrum. Dig Surg 18:102-110
19. Sobin LE, Whitekind CH (eds) (2001) TNM classification of malignant tumours. International Union Against Cancer, 5th ed. New York: John Wiley & Sons
20. Cohen P, Peehl DM, Stamey TA, Wilson KF, Clemmons DR, Rosenfeld RG (1993) Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients. J Clin Endocrinol Metab 76:1031-1035
21. Kanety H, Madjar Y, Dagan Y, Levi J, Papa MZ, Pariente C, Goldwasser B, Karasik A (1993) Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen. J Clin Endocrinol Metab 77:229-233
22. Boulle N, Logie A, Gicquel C, Perin L, Le Bouc Y (1998) Increased levels of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 are associated with malignancy in sporadic adrenocortical tumors. J Clin Endocrinol Metab 83:1713-1720
23. Wex H, Vorwerk P, Mohnike K, Bretschneider D, Kluba U, Aumann V, Blum WF, Mittler U (1998) Elevated serum levels of IGFBP-2 found in children suffering from acute leukaemia is accompanied by the occurrence of IGFBP-2 mRNA in the tumour clone. Br J Cancer 78:515-520
24. Busund LT, Richardsen E, Busund R, Ukkonen T, Bjornsen T, Busch C, Stalsberg H (2005) Significant expression of IGFBP2 in breast cancer compared with benign lesions. J Clin Pathol 58:361-366
25. Richardsen E, Ukkonen T, Bjnren T, Mortensen E, Egevad L, Busch C (2003) Overexpression of IGFBP2 is a marker for malignant transformation in prostate epithelium. Virchows Arch 442:329-335
26. Song SW, Fuller GN, Khan A, Kong S, Shen W, Taylor E, Ramdas L, Lanf FF, Zhang W (2003) IIp45, an insulin-like growth factor binding protein 2 (IGFBP2) binding protein, antagonizes IGFBP2 stimulation of glioma cell invasion. PNAS 100:13970-13975
27. Bubendorf L, Kolmer M, Kononen J, Koivisto P, Mousses S, Chen Y, Mahlamaki E, Schraml P, Moch H, Willi N, Elkahloun AG, Pretlow TG, Gasser TC, Mihatsch MJ, Sauter G, Kallioniemi OP (1999) Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays. J Natl Cancer Inst (Bethesda) 91:1758-1764
28. Fuller GN, Rhee CH, Hess KR, Caskey LS, Wang R, Bruner JM, Yung WK, Zhang W (1999) Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling. Cancer Res 59:4228-4232
29. Sato T, Yoshinaga K, Okabe S, Okawa T, Higuchi T, Enomoto M, Takizawa T, Sugihara K (2003) Cyclooxygenase-2 expression and its relationship with proliferation of colorectal adenomas. Jpn J Clin Oncol 33:631-635